Cargando…
Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy
Protein disulfide isomerase A3 (PDIA3) is a kind of thiol oxidoreductase with a wide range of functions, and its expression is elevated in a variety of tumors, which is closely related to the invasion and metastasis of tumor cells, and has a significant impact on the immunogenicity of tumor cells. A...
Autores principales: | Zhang, Jing, Wang, Kai, Hainisayimu, Tuersun, Li, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423987/ https://www.ncbi.nlm.nih.gov/pubmed/36046686 http://dx.doi.org/10.1155/2022/9614819 |
Ejemplares similares
-
m6A reading protein RBMX as a biomarker for prognosis and tumor progression in esophageal cancer
por: Tuersun, Hainisayimu, et al.
Publicado: (2023) -
Pan-Cancer Analysis of the Immunological Role of PDIA5: A Potential Target for Immunotherapy
por: Chen, Yu, et al.
Publicado: (2022) -
PDIA4 Correlates with Poor Prognosis and is a Potential Biomarker in Glioma
por: Li, Haoyu, et al.
Publicado: (2021) -
A nomogram model based on the number of examined lymph nodes–related signature to predict prognosis and guide clinical therapy in gastric cancer
por: Li, Huling, et al.
Publicado: (2022) -
Expression and Prognostic Significance of PDIA3 in Cervical Cancer
por: Zhang, Jing, et al.
Publicado: (2022)